Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Patient engagement during COVID-19 [whitepaper]

Does a health crisis change digital engagement behaviors? How should digital marketers respond?

Continue reading

A delicate balance: How clinical trial patient engagement benefits from technology with a human touch [Whitepaper]

Can we apply customer service models to healthcare? And what would that mean for clinical trial patient recruitment?

Continue reading

Top 3 clinical trial recruitment challenges – and how to beat them

Every clinical trial planning process hits bumps in the road now and then, but a few common clinical trial recruitment challenges consistently slow the research process and keep new treatments out of patient hands. The solutions to the most common challenges aren’t necessarily simple, but they do start from the most important place – the patient perspective.

Continue reading

Digital patient recruitment: How to reach the right patients

Ask any two trial sponsors how they feel about digital patient recruitment, and you’re likely to get two very different responses. Some have a positive experience and are able to reach their trial’s goals faster than they have with traditional methods. But others will warn you against a digital approach, citing unresponsive patients and wasted budget. It’s true that digital patient recruitment, ...

Continue reading

[Case Study] How we saved our client 30% per patient in a recent trial

At Antidote, we’re finding new and better ways to connect patients to clinical trials every day. We’re proud of the innovative methods we use to drive high quality referrals for our client’s trials. In fact, we’re always innovating — even with pricing models. Take our calibration model, for example. Calibration involves an upfront flat fee paid by the sponsor to measure the per-patient cost for ...

Continue reading

5 patient recruitment strategies that actually work

The most successful patient recruitment strategies are executed by recruitment companies that are always a few steps ahead. They reach patients just as they’re considering taking part in research. They verify information before sending patients to research sites. They answer questions before patients have the chance to ask them.

Continue reading

SCOPE 2020: Balancing technology with human touch, for results

Later this month, our team will be making the trip to Orlando to attend this year’s SCOPE Summit. We’re looking forward to connecting with some of the best minds in clinical operations to share best practices that continue to drive innovation in the space.

Continue reading

How patient recruitment materials can make or break your campaign

Patient recruitment materials developed by clinical trial recruitment companies have to achieve more than simply passing an IRB’s careful inspection. While guideline adherence is critical, it’s just as important that materials capture patient interest, answer key questions, and guide would-be participants to the next step toward your trial.

Continue reading

What 4,000 patients taught us about driving diversity in clinical trials

In order for medications to work effectively for all who need them, clinical trials need to include a diverse cross-section of the population. And yet, though nearly 40% of the population in the United States are racial and ethnic minorities, estimated rates of research participation for these groups range from 2% to 16%.

Continue reading

5 ways to drive innovative patient recruitment in 2020

It's a new year and a new decade with much promise, especially in drug development. New digital technologies, from telemedicine to wearables and new medical devices will continue to change the industry. AI and machine learning hold the exciting potential to accelerate new treatments and potential cures. With all that technology has changed within the drug development process, there are many more ...

Continue reading

Get our latest posts in your inbox